These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6204370)

  • 1. [Immunological aspects of herpes simplex virus infection].
    Virelizier JL
    Rev Prat; 1983 Dec; 33(55):3003-9. PubMed ID: 6204370
    [No Abstract]   [Full Text] [Related]  

  • 2. Cell-mediated immunity and immunosuppression in herpes simplex virus infection.
    Rinaldo CR; Torpey DJ
    Immunodeficiency; 1993; 5(1):33-90. PubMed ID: 8167747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of primary and memory cytotoxic T lymphocyte responses to herpes simplex virus 1 infection: granzyme B mediated CTL activity.
    Gorgian Mohammadi M; Bamdad T; Parsania M; Hashemi HR; Puyanfard S
    Iran J Immunol; 2009 Mar; 6(1):22-7. PubMed ID: 19293474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities.
    Yasukawa M; Zarling JM
    J Immunol; 1984 Nov; 133(5):2736-42. PubMed ID: 6207243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent herpes simplex virus infection. Part III: immunological aspects.
    Kane J; Tesini D; Ficarelli J
    J Pedod; 1977; 1(3):225-39. PubMed ID: 270574
    [No Abstract]   [Full Text] [Related]  

  • 6. [Analysis of protective mechanism against herpes simplex virus (HSV) infection in mice (author's transl)].
    Nagafuchi S
    Fukuoka Igaku Zasshi; 1980 Jul; 71(7):353-64. PubMed ID: 6260612
    [No Abstract]   [Full Text] [Related]  

  • 7. Cellular interactions in the cytotoxic T lymphocyte response to herpes simplex virus antigens: differential antigen activation requirements for the helper T lymphocyte and cytotoxic T lymphocyte precursors.
    Schmid DS; Rouse BT
    J Immunol; 1983 Jul; 131(1):479-84. PubMed ID: 6223080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of stress on memory cytotoxic T lymphocyte-mediated protection against herpes simplex virus infection at mucosal sites.
    Wonnacott KM; Bonneau RH
    Brain Behav Immun; 2002 Apr; 16(2):104-17. PubMed ID: 11908921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herpes simplex virus-specific human cytotoxic T-cell colonies expressing either gamma delta or alpha beta T-cell receptor: role of accessory molecules on HLA-unrestricted killing of virus-infected targets.
    Maccario R; Comoli P; Percivalle E; Montagna D; Locatelli F; Gerna G
    Immunology; 1995 May; 85(1):49-56. PubMed ID: 7635521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Host immune response to herpes simplex virus infection].
    Hayashi K
    Uirusu; 1989 Jun; 39(1):1-19. PubMed ID: 2481368
    [No Abstract]   [Full Text] [Related]  

  • 11. Phenotypic identification of antigen-dependent and antigen-independent CD8 CTL precursors in the draining lymph node during acute cutaneous herpes simplex virus type 1 infection.
    McNally JM; Dempsey D; Wolcott RM; Chervenak R; Jennings SR
    J Immunol; 1999 Jul; 163(2):675-81. PubMed ID: 10395657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Migratory dendritic cells: sometimes simply ferries?
    Randolph GJ
    Immunity; 2006 Jul; 25(1):15-8. PubMed ID: 16860753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro induction of human cell-mediated cytotoxicity directed against herpes simplex virus-infected cells: characterization of the effector lymphocyte.
    Rola-Pleszczynski M
    J Immunol; 1980 Oct; 125(4):1475-80. PubMed ID: 6967905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cycle of human herpes simplex virus infection: virus transport and immune control.
    Cunningham AL; Diefenbach RJ; Miranda-Saksena M; Bosnjak L; Kim M; Jones C; Douglas MW
    J Infect Dis; 2006 Sep; 194 Suppl 1():S11-8. PubMed ID: 16921466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens.
    Yasukawa M; Zarling JM
    J Immunol; 1984 Jul; 133(1):422-7. PubMed ID: 6609990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravascular naked DNA vaccine encoding glycoprotein B induces protective humoral and cellular immunity against herpes simplex virus type 1 infection in mice.
    Cui FD; Asada H; Kishida T; Itokawa Y; Nakaya T; Ueda Y; Yamagishi H; Gojo S; Kita M; Imanishi J; Mazda O
    Gene Ther; 2003 Dec; 10(25):2059-66. PubMed ID: 14595378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine genetic adjuvant facilitates prophylactic intravascular DNA vaccine against acute and latent herpes simplex virus infection in mice.
    Cui FD; Asada H; Jin ML; Kishida T; Shin-Ya M; Nakaya T; Kita M; Ishii M; Iwai M; Okanoue T; Imanishi J; Mazda O
    Gene Ther; 2005 Jan; 12(2):160-8. PubMed ID: 15470476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance of nude mice to herpes simplex virus and correlation with in vitro production of interferon.
    Zawatzky R; Hilfenhaus J; Krichner H
    Cell Immunol; 1979 Oct; 47(2):424-8. PubMed ID: 314862
    [No Abstract]   [Full Text] [Related]  

  • 19. Cell-mediated immunity to herpes simplex virus: induction of cytotoxic T lymphocyte responses by viral antigens incorporated into liposomes.
    Lawman MJ; Naylor PT; Huang L; Courtney RJ; Rouse BT
    J Immunol; 1981 Jan; 126(1):304-8. PubMed ID: 6969745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dancing with the enemy: the interplay of herpes simplex virus with dendritic cells.
    Novak N; Peng WM
    Clin Exp Immunol; 2005 Dec; 142(3):405-10. PubMed ID: 16297150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.